BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2009538)

  • 1. Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor.
    Mueller BM; Romerdahl CA; Trent JM; Reisfeld RA
    Cancer Res; 1991 Apr; 51(8):2193-8. PubMed ID: 2009538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells.
    Fischer EG; Ruf W; Mueller BM
    Cancer Res; 1995 Apr; 55(8):1629-32. PubMed ID: 7712465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.
    Naramura M; Gillies SD; Mendelsohn J; Reisfeld RA; Mueller BM
    Cancer Immunol Immunother; 1993 Oct; 37(5):343-9. PubMed ID: 8402738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.
    Cassard L; Cohen-Solal JF; Galinha A; Sastre-Garau X; Mathiot C; Galon J; Dorval T; Bernheim A; Fridman WH; Sautès-Fridman C
    J Clin Invest; 2002 Nov; 110(10):1549-57. PubMed ID: 12438452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
    Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
    Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts.
    Salcedo R; Martins-Green M; Gertz B; Oppenheim JJ; Murphy WJ
    Clin Cancer Res; 2002 Aug; 8(8):2655-65. PubMed ID: 12171898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
    Yang XD; Jia XC; Corvalan JR; Wang P; Davis CG; Jakobovits A
    Cancer Res; 1999 Mar; 59(6):1236-43. PubMed ID: 10096554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
    Fodstad O; Kjønniksen I; Aamdal S; Nesland JM; Boyd MR; Pihl A
    Cancer Res; 1988 Aug; 48(15):4382-8. PubMed ID: 3390834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro properties of human melanoma cells metastatic in nude mice.
    Herlyn D; Iliopoulos D; Jensen PJ; Parmiter A; Baird J; Hotta H; Adachi K; Ross AH; Jambrosic J; Koprowski H
    Cancer Res; 1990 Apr; 50(8):2296-302. PubMed ID: 2156614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
    Sabzevari H; Reisfeld RA
    Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.
    Rodeck U; Herlyn M; Herlyn D; Molthoff C; Atkinson B; Varello M; Steplewski Z; Koprowski H
    Cancer Res; 1987 Jul; 47(14):3692-6. PubMed ID: 3297307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor.
    Takahashi H; Herlyn D; Atkinson B; Powe J; Rodeck U; Alavi A; Bruce DA; Koprowski H
    Cancer Res; 1987 Jul; 47(14):3847-50. PubMed ID: 3594441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
    Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N; Ueda M; Ozawa S; Abe O; Shimizu N
    Cancer Res; 1989 Dec; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
    Perera RM; Narita Y; Furnari FB; Gan HK; Murone C; Ahlkvist M; Luwor RB; Burgess AW; Stockert E; Jungbluth AA; Old LJ; Cavenee WK; Scott AM; Johns TG
    Clin Cancer Res; 2005 Sep; 11(17):6390-9. PubMed ID: 16144944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.